• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中自噬溶酶体途径功能障碍;来自人类遗传学的证据。

Autophagy lysosomal pathway dysfunction in Parkinson's disease; evidence from human genetics.

机构信息

Montreal Neurological Institute, McGill University, Montréal, QC, H3A 1A1, Canada; First Pavlov State Medical University of St. Petersburg, St. Petersburg, Russia; Petersburg Nuclear Physics Institute Named By B.P. Konstantinov of National Research Centre «Kurchatov Institute», Gatchina, Russia; Department of Human Genetics, McGill University, Montréal, QC, H3A 1A1, Canada.

Department of Neurology and Neurosurgery, McGill University, Montréal, QC, H3A 1A1, Canada; Montreal Neurological Institute, McGill University, Montréal, QC, H3A 1A1, Canada; Department of Human Genetics, McGill University, Montréal, QC, H3A 1A1, Canada.

出版信息

Parkinsonism Relat Disord. 2020 Apr;73:60-71. doi: 10.1016/j.parkreldis.2019.11.015. Epub 2019 Nov 17.

DOI:10.1016/j.parkreldis.2019.11.015
PMID:31761667
Abstract

In recent years, multiple lines of evidence from human genetic and molecular studies have highlighted the importance of the autophagy lysosomal pathway (ALP) in Parkinson's disease (PD). Genes such as GBA and LRRK2, which harbor some of the most common mutations associated with PD, have essential roles in the ALP. α-synuclein, encoded by the SNCA gene, is degraded mainly by the ALP, and mutations/multiplications in SNCA may lead to impairment of chaperone mediated autophagy or other ALP functions. Numerous other PD-related genes, such as PRKN, PINK1, TMEM175, SMPD1, CTSD, CTSB and many more, have also been reported to have important roles in the ALP. Understanding the relationship between ALP impairment and PD pathogenesis may be crucial for uncovering the mechanisms underlying PD, and for the development of long-awaited neuroprotective therapies. In this review, we will discuss the data linking the ALP to PD (other, atypical forms of Parkinsonism, will not be discussed in this review). We will focus on evidence from studies on specific genes and proteins, their roles in the ALP, and the potential mechanisms underlying the involvement of these genes in PD.

摘要

近年来,来自人类遗传和分子研究的多方面证据强调了自噬溶酶体途径 (ALP) 在帕金森病 (PD) 中的重要性。携带与 PD 相关的一些最常见突变的基因,如 GBA 和 LRRK2,在 ALP 中具有重要作用。α-突触核蛋白,由 SNCA 基因编码,主要通过 ALP 降解,而 SNCA 的突变/扩增可能导致伴侣介导的自噬或其他 ALP 功能受损。许多其他与 PD 相关的基因,如 PRKN、PINK1、TMEM175、SMPD1、CTSD、CTSB 等,也被报道在 ALP 中具有重要作用。了解 ALP 损伤与 PD 发病机制之间的关系可能对揭示 PD 的机制以及开发期待已久的神经保护疗法至关重要。在这篇综述中,我们将讨论将 ALP 与 PD 联系起来的研究数据(其他非典型帕金森病形式不在本次综述讨论范围内)。我们将重点讨论特定基因和蛋白质的研究证据,它们在 ALP 中的作用,以及这些基因参与 PD 的潜在机制。

相似文献

1
Autophagy lysosomal pathway dysfunction in Parkinson's disease; evidence from human genetics.帕金森病中自噬溶酶体途径功能障碍;来自人类遗传学的证据。
Parkinsonism Relat Disord. 2020 Apr;73:60-71. doi: 10.1016/j.parkreldis.2019.11.015. Epub 2019 Nov 17.
2
Autophagy and Alpha-Synuclein: Relevance to Parkinson's Disease and Related Synucleopathies.自噬与α-突触核蛋白:与帕金森病及相关突触核蛋白病的关联
Mov Disord. 2016 Feb;31(2):178-92. doi: 10.1002/mds.26477. Epub 2016 Jan 27.
3
Constitutive silencing of LRRK2 kinase activity leads to early glucocerebrosidase deregulation and late impairment of autophagy in vivo.LRRK2 激酶活性的组成性沉默导致体内早期葡萄糖脑苷脂酶失调和晚期自噬损伤。
Neurobiol Dis. 2021 Nov;159:105487. doi: 10.1016/j.nbd.2021.105487. Epub 2021 Aug 20.
4
Dysfunction of the autophagy/lysosomal degradation pathway is a shared feature of the genetic synucleinopathies.自噬/溶酶体降解途径的功能障碍是遗传突触核蛋白病的共同特征。
FASEB J. 2013 Sep;27(9):3424-9. doi: 10.1096/fj.12-223842. Epub 2013 May 16.
5
The vicious cycle between α-synuclein aggregation and autophagic-lysosomal dysfunction.α-突触核蛋白聚集与自噬溶酶体功能障碍之间的恶性循环。
Mov Disord. 2020 Jan;35(1):34-44. doi: 10.1002/mds.27895. Epub 2019 Nov 15.
6
Lysosomal impairment in Parkinson's disease.帕金森病中的溶酶体损伤。
Mov Disord. 2013 Jun;28(6):725-32. doi: 10.1002/mds.25462. Epub 2013 Apr 11.
7
LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's disease.LRRK2、GBA 及其在自噬调节中的相互作用:对帕金森病治疗的影响。
Transl Neurodegener. 2022 Jan 31;11(1):5. doi: 10.1186/s40035-022-00281-6.
8
Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia.GBA 相关帕金森病和路易体痴呆风险和发病年龄的遗传修饰物。
Brain. 2020 Jan 1;143(1):234-248. doi: 10.1093/brain/awz350.
9
Lysosomal Pathogenesis of Parkinson's Disease: Insights From LRRK2 and GBA1 Rodent Models.帕金森病的溶酶体发病机制:来自 LRRK2 和 GBA1 啮齿动物模型的见解。
Neurotherapeutics. 2023 Jan;20(1):127-139. doi: 10.1007/s13311-022-01290-z. Epub 2022 Sep 9.
10
Heterozygous GBA D409V and ATP13a2 mutations do not exacerbate pathological α-synuclein spread in the prodromal preformed fibrils model in young mice.杂合 GBA D409V 和 ATP13a2 突变不会加剧年轻小鼠前驱性预形成纤维模型中病理性 α-突触核蛋白的传播。
Neurobiol Dis. 2021 Nov;159:105513. doi: 10.1016/j.nbd.2021.105513. Epub 2021 Sep 16.

引用本文的文献

1
Recombinant cathepsins B and L promote α-synuclein clearance and restore lysosomal function in human and murine models with α-synuclein pathology.重组组织蛋白酶B和L可促进α-突触核蛋白的清除,并在患有α-突触核蛋白病理学的人类和小鼠模型中恢复溶酶体功能。
Mol Neurodegener. 2025 Aug 29;20(1):95. doi: 10.1186/s13024-025-00886-1.
2
Acupuncture for Parkinson's Disease: A Narrative Review of Clinical Efficacy and Mechanistic Insights.针灸治疗帕金森病:临床疗效与作用机制的叙述性综述
Neuropsychiatr Dis Treat. 2025 Aug 22;21:1731-1750. doi: 10.2147/NDT.S532027. eCollection 2025.
3
Cathepsins in Neurological Diseases.
神经疾病中的组织蛋白酶
Int J Mol Sci. 2025 Aug 15;26(16):7886. doi: 10.3390/ijms26167886.
4
Advancing precision medicine therapeutics for Parkinson's utilizing a shared quantitative systems pharmacology model and framework.利用共享的定量系统药理学模型和框架推进帕金森病的精准医学治疗。
Front Syst Biol. 2024 Mar 8;4:1351555. doi: 10.3389/fsysb.2024.1351555. eCollection 2024.
5
Immunosenescence: signaling pathways, diseases and therapeutic targets.免疫衰老:信号通路、疾病与治疗靶点。
Signal Transduct Target Ther. 2025 Aug 6;10(1):250. doi: 10.1038/s41392-025-02371-z.
6
Hyperparameter tuned deep learning-driven medical image analysis for intracranial hemorrhage detection.用于颅内出血检测的超参数调优深度学习驱动的医学图像分析
PLoS One. 2025 Jul 28;20(7):e0326255. doi: 10.1371/journal.pone.0326255. eCollection 2025.
7
Nurr1 deficiency impairs autophagy-lysosomal function through GBA-dependent transcriptional regulation in Parkinson's disease pathogenesis.在帕金森病发病机制中,Nurr1缺乏通过GBA依赖性转录调控损害自噬-溶酶体功能。
Front Aging Neurosci. 2025 Jun 30;17:1612389. doi: 10.3389/fnagi.2025.1612389. eCollection 2025.
8
Targeting the Interplay Between Autophagy and the Nrf2 Pathway in Parkinson's Disease with Potential Therapeutic Implications.靶向帕金森病中自噬与Nrf2信号通路的相互作用及其潜在治疗意义
Biomolecules. 2025 Jan 19;15(1):149. doi: 10.3390/biom15010149.
9
The Parkinson's disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons.帕金森病风险基因组织蛋白酶 B 促进多巴胺能神经元中纤维状 α-突触核蛋白的清除、溶酶体功能和葡萄糖脑苷脂酶活性。
Mol Neurodegener. 2024 Nov 25;19(1):88. doi: 10.1186/s13024-024-00779-9.
10
The potential of natural products to inhibit abnormal aggregation of α-Synuclein in the treatment of Parkinson's disease.天然产物在帕金森病治疗中抑制α-突触核蛋白异常聚集的潜力。
Front Pharmacol. 2024 Oct 23;15:1468850. doi: 10.3389/fphar.2024.1468850. eCollection 2024.